Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph F Goldberg

Showing results (1-10 of 175) with videos related to

Pageof 18
Sort By:
The Journal of Clinical Psychiatry|January 5, 2022
Ketamine and Cognitive Function in Depression: Detrimental, Neutral, or Advantageous?Joseph F Goldberg
Bipolar Disorders|August 18, 2010
Ruling in and ruling out 'caseness' in the bipolar spectrum: implications for initial screeningJoseph F Goldberg
CNS Spectrums|April 24, 2010
Differential diagnosis of bipolar disorderJoseph F Goldberg
The Journal of Clinical Psychiatry|October 16, 2022
Living in a Pharmacologically Imperfect WorldJoseph F Goldberg
Journal of Affective Disorders|August 4, 2012
A preliminary open trial of nefazodone added to mood stabilizers for bipolar depressionJoseph F Goldberg
The Journal of Clinical Psychiatry|January 12, 2021
How Much Is the Debate Over Antidepressant Efficacy and Safety in Bipolar Depression an Artifact of Study Methodologies?Joseph F Goldberg
The Journal of Clinical Psychiatry|December 18, 2019
Does Pharmacogenomic Testing Meaningfully Improve Antidepressant Treatment Outcomes When Looking Only at Patients Taking Phase I Hepatically Metabolized Drugs? A LittleJoseph F Goldberg
The Journal of Clinical Psychiatry|May 15, 2012
Lowering the diagnostic threshold for bipolar disorder: the wrong stuff?Joseph F Goldberg
The Journal of Clinical Psychiatry|August 24, 2021
How Should Psychiatry Respond to COVID-19 Anti-Vax Attitudes?Joseph F Goldberg
The Journal of Clinical Psychiatry|June 12, 2020
Are (Some) Antipsychotics Depressogenic in Bipolar Disorder?Joseph F Goldberg
Pageof 18

Showing results (1-10 of 175) with videos related to

Sort By:
Pageof 18
The Journal of Clinical Psychiatry|January 5, 2022
Ketamine and Cognitive Function in Depression: Detrimental, Neutral, or Advantageous?Joseph F Goldberg
Bipolar Disorders|August 18, 2010
Ruling in and ruling out 'caseness' in the bipolar spectrum: implications for initial screeningJoseph F Goldberg
CNS Spectrums|April 24, 2010
Differential diagnosis of bipolar disorderJoseph F Goldberg
The Journal of Clinical Psychiatry|October 16, 2022
Living in a Pharmacologically Imperfect WorldJoseph F Goldberg
Journal of Affective Disorders|August 4, 2012
A preliminary open trial of nefazodone added to mood stabilizers for bipolar depressionJoseph F Goldberg
The Journal of Clinical Psychiatry|January 12, 2021
How Much Is the Debate Over Antidepressant Efficacy and Safety in Bipolar Depression an Artifact of Study Methodologies?Joseph F Goldberg
The Journal of Clinical Psychiatry|December 18, 2019
Does Pharmacogenomic Testing Meaningfully Improve Antidepressant Treatment Outcomes When Looking Only at Patients Taking Phase I Hepatically Metabolized Drugs? A LittleJoseph F Goldberg
The Journal of Clinical Psychiatry|May 15, 2012
Lowering the diagnostic threshold for bipolar disorder: the wrong stuff?Joseph F Goldberg
The Journal of Clinical Psychiatry|August 24, 2021
How Should Psychiatry Respond to COVID-19 Anti-Vax Attitudes?Joseph F Goldberg
The Journal of Clinical Psychiatry|June 12, 2020
Are (Some) Antipsychotics Depressogenic in Bipolar Disorder?Joseph F Goldberg
Pageof 18